|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 231/54 | (2006.01) |
| (11) | Number of the document | 2651902 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11807826.0 |
| Date of filing the European patent application | 2011-12-19 | |
| (97) | Date of publication of the European application | 2013-10-23 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-08 |
| (46) | Date of publication of the claims translation | 2018-01-10 |
| (86) | Number | PCT/US2011/065897 |
| Date | 2011-12-19 |
| (87) | Number | WO 2012/083306 |
| Date | 2012-06-21 |
| (30) | Number | Date | Country code |
| 201061424601 P | 2010-12-17 | US |
| (72) |
ANDERSON, Eric, US
BOLTON, Gary, L., US
CAPRATHE, Bradley, US
JIANG, Xin, US
LEE, Chitase, US
ROARK, William, H., US
VISNICK, Melean, US
|
| (73) |
Reata Pharmaceuticals, Inc.,
2801 Gateway Drive, Suite 150, Irving, TX 75063-2648,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Tricikliniai pirazolil- ir pirimidinilenonai, kaip antioksidantų uždegimo moduliatoriai |
| PYRAZOLYL AND PYRIMIDINYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 14 | 289.00 EUR |
| 2025-12-19 |